Literature DB >> 17448573

Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.

Lúcia Fernanda C da Costa Leite1, Rosa Helena Veras Mourão, Maria do Carmo Alves de Lima, Suely Lins Galdino, Marcelo Zaldini Hernandes, Francisco de Assis Rocha Neves, Stéphanie Vidal, Jacques Barbe, Ivan da Rocha Pitta.   

Abstract

New arylidene-thiazolidinediones (ATZDs) were synthesized and evaluated in the alloxan-induced hyperglycemia mice model. The molecular target taken into consideration is the nuclear PPAR-gamma whose crystallographic structure is available on the PDB database as 2PRG. Thus the hypoglycemic and hypolipidemic activities of compounds were compared with the result of their docking after removal of the co-crystallized ligand present in the 2PRG structure. Molecular modeling studies were carried out using the Autodock 3.0.5 and ADT 1.1 programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448573     DOI: 10.1016/j.ejmech.2007.02.015

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

Review 1.  Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.

Authors:  Amanda Karolina Soares Silva; Christina Alves Peixoto
Journal:  Cell Mol Life Sci       Date:  2018-05-22       Impact factor: 9.261

2.  A theoretical study of red-shifting and blue-shifting hydrogen bonds occurring between imidazolidine derivatives and PEG/PVP polymers.

Authors:  Boaz G Oliveira; Maria C A Lima; Ivan R Pitta; Suely L Galdino; Marcelo Z Hernandes
Journal:  J Mol Model       Date:  2009-06-12       Impact factor: 1.810

3.  Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats.

Authors:  Juan Manuel Decara; Miguel Romero-Cuevas; Patricia Rivera; Manuel Macias-González; Margarita Vida; Francisco J Pavón; Antonia Serrano; Carolina Cano; Nieves Fresno; Ruth Pérez-Fernández; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

4.  Computational and biological evaluation of N-octadecyl-N'-propylsulfamide, a selective PPARα agonist structurally related to N-acylethanolamines.

Authors:  Inmaculada Moreno-Santos; Francisco Javier Pavón; Miguel Romero-Cuevas; Antonia Serrano; Carolina Cano; Margarita Suardíaz; Juan Decara; Juan Suarez; Fernando Rodríguez de Fonseca; Manuel Macías-González
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

5.  LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).

Authors:  Amanda Karolina Soares e Silva; Dilênia de Oliveira Cipriano Torres; Fabiana Oliveira dos Santos Gomes; Bruna dos Santos Silva; Edlene Lima Ribeiro; Amanda Costa Oliveira; Laise Aline Martins dos Santos; Maria do Carmo Alves de Lima; Ivan da Rocha Pitta; Christina Alves Peixoto
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

6.  The isolation, Characterization and Preclinical Studies of Metal Complex of Thespesia populnea for the Potential Peroxisome Proliferator-activated Receptors-γ Agonist Activity.

Authors:  Mohini Ashok Phanse; Manohar Janardhan Patil; Konde Abbulu
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

7.  GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.

Authors:  Angélica A Amato; Senapathy Rajagopalan; Jean Z Lin; Bruno M Carvalho; Ana C M Figueira; Jenny Lu; Stephen D Ayers; Melina Mottin; Rodrigo L Silveira; Paulo C T Souza; Rosa H V Mourão; Mário J A Saad; Marie Togashi; Luiz A Simeoni; Dulcinéia S P Abdalla; Munir S Skaf; Igor Polikparpov; Maria C A Lima; Suely L Galdino; Richard G Brennan; John D Baxter; Ivan R Pitta; Paul Webb; Kevin J Phillips; Francisco A R Neves
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

8.  GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.

Authors:  Michella S Coelho; Caroline L de Lima; Carine Royer; Janaina B Silva; Fernanda C B Oliveira; Camila G Christ; Sidney A Pereira; Sonia N Bao; Maria C A Lima; Marina G R Pitta; Ivan R Pitta; Francisco A R Neves; Angélica A Amato
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

9.  Development of new 5-(chromene-3-yl)methylene-2,4-thiazolidinediones as antimicrobial agents.

Authors:  Cristina Mariana Nastasă; Mihaela Duma; Adrian Pîrnău; Laurian Vlase; Brînduşa Tiperciuc; Ovidiu Oniga
Journal:  Clujul Med       Date:  2016-01-15

10.  The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety.

Authors:  Florentina Geanina Lupascu; Oana Maria Dragostin; Liliana Foia; Dan Lupascu; Lenuta Profire
Journal:  Molecules       Date:  2013-08-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.